Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.
Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
NovoSeven as a universal haemostatic agent.
Overall experience with NovoSeven.
Structure of human coagulation activated factor VII.
Physiological function of tissue factor pathway inhibitor and interaction with heparins.
Cellular consequences upon factor VIIa binding to tissue factor.
Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells.
Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Recombinant factor VIIa does not induce hypercoagulability in vitro.
Structure of human factor VIIa and its implications for the triggering of blood coagulation.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
 
© Copyright 1999-2020 DocMD.com. All Rights Reserved.